June 18, 2013

Bayer HealthCare, makers of the Contour Next portfolio of blood-glucose meters, and dLife Healthcare Solutions, a diabetes behavior change solution, have created and are working together to offer Eat Well, Test Well, a six-week food and nutrition program for people with diabetes available at no charge.

May 20, 2013

CVS/pharmacy is reminding patients with diabetes that one of the most important ways they can manage their disease is to perform regular testing of their blood-sugar levels.

May 3, 2013

Women who take low-dose oral contraceptives may be at increased risk of chronic pelvic-pain symptoms and pain during sexual climax, according to a new study.

April 19, 2013

Abbott Diabetes Care last week initiated a voluntary recall of its FreeStyle lnsulinx Blood Glucose Meters in the United States.

April 10, 2013

Bartell Drugs will play a prominent role at a diabetes expo in Seattle this weekend, the retail pharmacy chain said Wednesday.

April 5, 2013

Novo Nordisk has launched a diabetes awareness sweepstakes in which the winners get a free trip to the 2013 IndyCar finale, the Danish drug maker said.

April 1, 2013

Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

April 1, 2013

The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

March 29, 2013

The Food and Drug Administration has approved a new drug made by Johnson & Johnson for treating Type 2 diabetes, the agency said.

March 25, 2013

LifeScan initiated a voluntary recall and replacement for all of its OneTouch VerioIQ blood-glucose meters in the United States, effective immediately.

March 25, 2013

SanMedica International introduced its SeroVital-HGH, a new oral human-growth hormone booster formulated with women in mind, at the Academy of Women's Health's Annual Congress.

March 15, 2013

The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.

March 7, 2013

The cost of diabetes has increased by more than $70 billion over the past five years, according to new research from the American Diabetes Association.

March 5, 2013

Drug maker Actavis is challenging the patent for a drug used to treat testosterone deficiency or absence in men, the company said.

February 19, 2013

Mylan and Biocon have a deal to develop and sell generic insulin-analog products for diabetes, Mylan said.

February 19, 2013

Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.

February 11, 2013

The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

February 5, 2013

The Food and Drug Administration has approved a testosterone gel product made by Perrigo, the drug maker said.

February 1, 2013

Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

January 31, 2013

A nutritional supplement may help ward off gestational diabetes in pregnant women, according to a new study.

January 30, 2013

A patch for treating menopause that the manufacturer calls the smallest is now available.

January 22, 2013

During its annual business review Tuesday, Johnson & Johnson announced that the recent introduction of the OneTouch Verio Glucose testing platform represented one of the first diabetes care devices to alert and display high/low patterns that deliver more meaningful and actionable insights to help patients better understand and manage their diabetes.

January 9, 2013

Four-time NBA champion John Salley will be heading here next week to attend the ECRM Vitamin, Diet and Sports Nutrition conference in support of Natural Product Solutions.

December 28, 2012

Mylan on Friday announced that its partner Famy Care has received final approval from the Food and Drug Administration for its abbreviated new drug application for levonorgestrel and ethinyl estradiol Tablets USP in the 0.15mg/0.03mg strength.